SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-15-000202
Filing Date
2015-05-15
Accepted
2015-05-15 17:19:16
Documents
5
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN ISSUER FOR THE PERIOD ENDED MARCH 31, 2015 nymoxPharma6kq1fs.htm 6-K 5673
2 QUARTERLY REPORT FOR THE QUARTER ENDED MARCH 31, 2015 exhibit99-1.htm EX-99.1 465680
3 CEO CERTIFICATIONS exhibit99-2.htm EX-99.2 6751
4 CFO CERTIFICATIONS exhibit99-3.htm EX-99.3 6709
5 exhibit99-1x1x1.jpg GRAPHIC 10722
  Complete submission text file 0001176256-15-000202.txt   500761
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 15870952
SIC: 2835 In Vitro & In Vivo Diagnostic Substances